Nearly half of phase III cancer clinical trials carried out by the NCI-sponsored SWOG Cancer Research Network were associated with clinical care guidelines or new drug approvals.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
